Regional Anatomic and Age Effects on Cell Function of Human Adipose-Derived Stem Cells
- 1 May 2008
- journal article
- northeastern society-of-plastic-surgeons
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 60 (5), 538-544
- https://doi.org/10.1097/sap.0b013e3181723bbe
Abstract
Adipose tissue has been shown to contain adult mesenchymal stem cells that have therapeutic applications in regenerative medicine. There is evidence that the ability of adipose precursor cells to grow and differentiate varies among fat depots and changes with age. Defining these variations in cell function and molecular mechanisms of adipogenesis will facilitate the development of cell-based therapies. We compared cells harvested from 5 different subcutaneous (SC) adipose depots in 12 female patients classified into 3 age ranges (25–30, 40–45, and 55–60 years old). Capacity for differentiation of isolated adipose-derived stem cells (ASCs) with and without ciglitazone, a strong peroxisome proliferatoractivated receptors (PPAR)-γ agonist, was assessed in vitro. ASCs were also characterized by lipolytic function, proliferation, and sensitivity to apoptosis. Additionally, PPAR-γ-2 protein expression was determined. We observed a difference in the apoptotic susceptibility of ASCs from various SC depots, with the superficial abdominal depot (above Scarpas layer) significantly more resistant to apoptosis when compared with the 4 other depots. We have also demonstrated that a PPAR-γ agonist aids in the induction of differentiation in cells from all depots and ages. Although sensitivity to apoptosis was linked to anatomic depot, differences in cell proliferation were related primarily to age. Stimulated free glycerol release has been shown to be highest in the arm depot. The arm depot has also consistently shown expression of PPAR-γ-2 with and without a PPAR-γ agonist. Younger patients have increased PPAR-γ-2 expression in all depots, whereas the older patients have consistent elevated expression only in the arm and thigh depots. We have shown there is variability in function of ASCs that have been harvested from different SC depots. Additionally, we have shown age-related changes in function. These data will help select patients and cell harvest sites most suitable for tissue engineering therapies.Keywords
This publication has 16 references indexed in Scilit:
- Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose TissueCellular Physiology and Biochemistry, 2004
- Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
- Adipose-derived stromal cells—their utility and potential in bone formationInternational Journal of Obesity, 2000
- Effect of troglitazone on body fat distribution in type 2 diabetic patients.Diabetes Care, 1999
- Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes.Diabetes Care, 1999
- Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.JCI Insight, 1997
- Regional adipocity in manJournal of Endocrinology, 1997
- Differences in Lipolysis between Human Subcutaneous and Omental Adipose TissuesAnnals of Medicine, 1995
- Regional adiposity and morbidity.Physiological Reviews, 1994
- Abdominal obesity and the development of noninsulin‐dependent diabetes mellitusDiabetes/Metabolism Research and Reviews, 1988